Ingevity Corporation (NGVT)

Ingevity Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Ingevity Corporation (NGVT) is a Chemicals - Specialty company based in US with a market capitalization of $2.4B. Revenue declined 17.0% year-over-year and the company generated $273.5M in free cash flow. This page tracks NGVT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 1.6K employees · IPO May 3, 2016

Valuation

Valuation & price

$67.58 · as of May 17, 2026 · -13.2% vs 52w high

P/E ratio

Latest-FY diluted EPS

79.74

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$77.87$59.36$40.85Jul 25Dec 25Jul 26Jul 7, 25$45.34Jul 9, 25$47.42Jul 11, 25$47.56Jul 15, 25$45.54Jul 17, 25$46.32Jul 21, 25$46.18Jul 23, 25$46.63Jul 25, 25$46.40Jul 29, 25$44.09Jul 31, 25$41.79Aug 4, 25$40.85Aug 6, 25$48.89Aug 11, 25$52.20Aug 13, 25$55.50Aug 15, 25$54.57Aug 19, 25$55.16Aug 21, 25$54.54Aug 25, 25$56.87Aug 27, 25$57.40Aug 29, 25$58.38Sep 3, 25$57.89Sep 5, 25$59.77Sep 9, 25$58.80Sep 11, 25$58.78Sep 16, 25$56.28Sep 18, 25$57.84Sep 22, 25$56.70Sep 24, 25$55.31Sep 26, 25$55.11Sep 30, 25$55.19Oct 2, 25$56.31Oct 6, 25$55.01Oct 8, 25$54.37Oct 10, 25$52.85Oct 14, 25$54.83Oct 16, 25$55.50Oct 21, 25$55.90Oct 23, 25$56.37Oct 27, 25$56.09Oct 29, 25$53.76Oct 31, 25$53.72Nov 4, 25$52.58Nov 6, 25$46.20Nov 10, 25$49.86Nov 12, 25$49.15Nov 14, 25$49.37Nov 18, 25$47.99Nov 20, 25$47.48Nov 25, 25$52.16Nov 28, 25$52.23Dec 2, 25$51.64Dec 4, 25$52.25Dec 8, 25$53.98Dec 10, 25$58.83Dec 12, 25$58.87Dec 16, 25$57.26Dec 18, 25$59.59Dec 22, 25$59.77Dec 24, 25$59.98Dec 29, 25$59.48Jan 2, 26$60.09Jan 6, 26$62.87Jan 8, 26$63.78Jan 12, 26$65.57Jan 14, 26$65.96Jan 16, 26$66.17Jan 21, 26$67.06Jan 23, 26$69.44Jan 27, 26$66.88Jan 29, 26$65.92Feb 2, 26$67.25Feb 4, 26$72.17Feb 9, 26$73.09Feb 11, 26$74.91Feb 13, 26$76.57Feb 18, 26$74.31Feb 20, 26$72.19Feb 24, 26$71.12Feb 26, 26$70.52Mar 2, 26$71.64Mar 4, 26$69.88Mar 6, 26$64.95Mar 10, 26$65.51Mar 12, 26$64.07Mar 17, 26$67.86Mar 19, 26$65.35Mar 23, 26$66.80Mar 25, 26$71.78Mar 27, 26$70.57Mar 31, 26$71.23Apr 2, 26$71.09Apr 7, 26$70.57Apr 9, 26$74.98Apr 13, 26$75.98Apr 15, 26$74.21Apr 17, 26$75.20Apr 22, 26$74.59Apr 24, 26$76.41Apr 28, 26$74.74Apr 30, 26$76.19May 4, 26$73.79May 6, 26$77.87May 8, 26$75.63May 12, 26$71.56May 14, 26$71.37May 18, 26$66.50May 20, 26$66.09May 22, 26$66.67May 28, 26$68.58Jun 1, 26$66.55Jun 3, 26$66.97Jun 5, 26$65.99Jun 9, 26$69.04Jun 11, 26$70.92Jun 15, 26$72.43Jun 17, 26$71.75Jun 22, 26$72.74Jun 24, 26$74.75Jun 26, 26$77.12Jul 2, 26$72.49
$40.4052-week range$77.87
Loading valuation history…

Fundamentals

Key fundamentals

$2.4B

Market cap

-17.0%

Revenue growth (YoY)

39.5%

Gross margin

$273.5M

Free cash flow (USD)

$1.2B

Net debt

-0.3%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Basic Materials

Sector

Trajectory

Long-term trends

Revenue by year

20162025

FY 2016$908.3MFY 2017$972.4MFY 2018$1.1BFY 2019$1.3BFY 2020$1.2BFY 2021$1.4BFY 2022$1.7BFY 2023$1.7BFY 2024$1.4BFY 2025$1.2B
$908.3M$1.2B

Free cash flow by year

20162025

FY 2016$71.2MFY 2017$121.7MFY 2018$158.1MFY 2019$160.9MFY 2020$246.5MFY 2021$189.5MFY 2022$170.9MFY 2023$95.3MFY 2024$51.0MFY 2025$273.5M
$71.2M$273.5M

Gross margin by year

20212025

FY 202136.9%FY 202234.2%FY 202327.9%FY 202432.3%FY 202539.5%
36.9%39.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCFO AppointmentJun 24, 2026Filing
  • Insider sellInsider Sell $34KDYER TERRANCE M · SVP, Chief HR Officer · $34KJun 1, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 4, 2026Filing
  • 8-K eventBusiness SaleApr 15, 2026Filing

Questions

Frequently asked questions

What is Ingevity Corporation's market cap?

Ingevity Corporation (NGVT) has a market capitalization of $2.4B.

What is NGVT's P/E ratio?

A meaningful P/E ratio is not available for NGVT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is NGVT's price-to-book (P/B) ratio?

NGVT trades at 79.74 times book value per share.

Are insiders buying NGVT stock?

SEC Form 4 filings show no open-market insider buys at Ingevity Corporation in the last 90 days (1 sell).

Same arena

Related companies in Chemicals - Specialty

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.